Abnormalities of molecules associated with the glutamate synapse have been
implicated in the pathophysiology of schizophrenia. Of the many glutamate r
eceptors, those most commonly suggested to be involved in schizophrenia are
the ionotropic subtypes, the NMDA, AMPA, and kainate receptors. Both the N
MDA and AMPA subtypes have berl? extensively studied in postmortem brains o
f individuals with schizophrenia, but relatively little is known about the
expression of the kainate subtype of glutamate receptor. In this study, we
have determined cortical and striatal kainate receptor expression in brains
from persons with schizophrenia and a comparison group, using both in situ
hybridization and receptor autoradiography. At the level of subunit mRNA e
xpression, a shift in subunit stoichiometry teas evident in multiple region
s of the prefrontal cortex, with increased expression of gluR7 mRNA and dec
reased expression of KA2 mRNA. Decreased kainate receptor binding was also
observed in the subjects with schizophrenia, but was restricted to infragra
nular laminae of tire prefrontal cortex. No differences in kainate receptor
binding or subunit mRNA levels were found ill striatum or occipital cortex
, suggesting that these findings may be restricted to association cortex. T
hese data add to the gr growing literature implicating ionotropic glutamate
receptor disturbances in schizophrenia, and indicate that in addition to A
MPA and NMDA receptors, the kainate receptors are also abnormally expressed
in this illness. (C) 2001 American College of Neuropsychopharmacology. Pub
lished by Elsevier Science Inc.